from the October 2013 issue
BioLineRX obtains FDA orphan drug status for leukemia drug
The company has obtained orphan drugs designation for
BL-8040 as a therapeutic for the treatment of acute myeloid leukemia.
Reprinted from the Israel High-Tech & Investment Report October 2013
Click HERE to request further information.
Click HERE to go BACK.